This HTML5 document contains 146 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43118400
rdf:type
wikibase:Item
schema:description
مقالة علمية نشرت في 7 مارس 2010 2010年学术文章 2010年の論文 wissenschaftlicher Artikel 2010年学术文章 מאמר מדעי artikull shkencor artikel ilmiah artykuł naukowy мақолаи илмӣ vitskapeleg artikkel 2010年学术文章 naučni članak artículo científico publicado en 2010 articol științific scientific article published on 7 March 2010 artigo científico บทความทางวิทยาศาสตร์ vedecký článok научни чланак teaduslik artikkel ৭ মার্চ ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научная статья 2010 nî lūn-bûn 2010年學術文章 tudományos cikk bài báo khoa học artigo científico vědecký článek 2010년 논문 scienca artikolo 2010年學術文章 научни чланак 2010年学术文章 scientific article published on 7 March 2010 videnskabelig artikel наукова стаття, опублікована в березні 2010 2010年學術文章 artikulong pang-agham 2010年学术文章 научна статия 2010 թվականի մարտի 7-ին հրատարակված գիտական հոդված article scientifique vetenskaplig artikel bilimsel makale artículu científicu espublizáu en 2010 article científic articolo scientifico 2010年学术文章 article scientific 2010年學術文章 vitenskapelig artikkel wetenschappelijk artikel artigo científico επιστημονικό άρθρο სამეცნიერო სტატია scientific article published on 7 March 2010 2010年學術文章 tieteellinen artikkeli
p:P577
wds:Q43118400-2A5639AA-2F56-4400-8CA2-34E9CE851DEF
wdt:P577
2010-03-07T00:00:00Z
p:P407
wds:Q43118400-CE681C79-3F7E-45DF-A797-62BF947885DB
wdt:P407
wd:Q1860
p:P2093
wds:Q43118400-C97547AF-B9B2-4937-AB98-A61AB2577F5F wds:Q43118400-C23F7484-4D2C-435D-B33A-7BF4F2CF1D3E wds:Q43118400-AEDAB65B-64BE-48D6-B5AE-06532F0E690E wds:Q43118400-D27BDE38-2DC0-457C-A624-44F848BB3213 wds:Q43118400-CA46F970-4036-4D1D-9B78-4E21B12773F8 wds:Q43118400-EF9E3125-0713-4BFD-BF57-129A059D926C wds:Q43118400-D59A781C-AD54-4105-8B09-F33F9247E49B wds:Q43118400-060B78A4-20F2-4C12-B97E-D088D968027C wds:Q43118400-1DF14254-C83A-4BA5-A194-47490B571F7D wds:Q43118400-1AD62B64-2106-4859-A4F3-7EDEF25FBE1B wds:Q43118400-0759040D-3127-4104-8A05-FA5F0A523ECC wds:Q43118400-34D88AC6-7857-49D3-8B0D-B60BFB6BDE41 wds:Q43118400-1EE416CF-F467-4E93-B41D-80855CA98B59 wds:Q43118400-5B0F171A-8ACC-4D0D-9C04-FB4332EA4819 wds:Q43118400-43619A7E-C200-4B1B-BFE5-60BF7B21BCE9 wds:Q43118400-412573BD-D6B7-45E9-8627-47384A485761 wds:Q43118400-6F01387F-7572-41D4-BD84-BF9A0450631D wds:Q43118400-8FBCA18D-F66C-4F97-9445-43467E011994 wds:Q43118400-8B737C6E-2D2B-44B0-8441-AA9E506BA202 wds:Q43118400-8170BF19-D249-4BDE-8E8D-78F29ABE5658 wds:Q43118400-A0348790-7FA2-4300-825A-5EE20DF15CC7 wds:Q43118400-9D2E77C8-B826-4FED-9120-A6F009E412F0 wds:Q43118400-99C9911B-E2F8-4C34-89C0-1D45B4730F87 wds:Q43118400-AC16F0CD-D4B7-4191-B3D8-9306B4008BB5 wds:Q43118400-AA68C4C7-E8E1-47F9-A285-B1E5E024C76D wds:Q43118400-A97A89E0-AE78-4457-8B01-1CBE3772317B wds:Q43118400-A6057859-A580-4E23-99FF-89AA6216196B
wdt:P2093
Derek Beauchamp Kenneth Rhodes Mark Ault Jeffrey Crooke Daniel Hall Vernon Alford Kristen Hansen Devraj Chakravarty J Kent Barbay Brian C Shook Aihua Wang Karen Carroll Nathaniel Wallace Xun Li Lori Westover Sandra Damon Kenneth Wells Mark T Powell Ronald Russell Paul F Jackson Shawn Branum Stefanie Rassnick Kristi Leonard Kenneth C Rupert James L Bullington Lisa Lampron Scott Youells
rdfs:label
Optimization of arylindenopyrimidines as potent adenosine A Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists
skos:prefLabel
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists Optimization of arylindenopyrimidines as potent adenosine A
schema:name
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists Optimization of arylindenopyrimidines as potent adenosine A
p:P50
wds:Q43118400-7043479A-AC71-4E00-B23C-DFFCDDB53E99 wds:Q43118400-98820465-3D2F-43AA-9900-C063BD49232D
wdt:P50
wd:Q37381367 wd:Q43116801
p:P1476
wds:Q43118400-5F9F2801-1074-45B8-8F1E-63185459C89C
wdt:P1476
Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists
p:P304
wds:Q43118400-9960DDFC-2952-4589-BB34-1AC9CEED8B9F
wdt:P304
2868-2871
p:P31
wds:Q43118400-3D5DD550-0CFA-4AC4-964A-19CCBC420892
wdt:P31
wd:Q13442814
p:P698
wds:Q43118400-5024E66A-C356-4EC0-854A-104874B66B19
wdtn:P698
n6:20338760
wdt:P698
20338760
p:P1433
wds:Q43118400-6C6A2FE6-0DBB-412A-9008-4236C47B9EBC
wdt:P1433
wd:Q2709483
p:P433
wds:Q43118400-1B79732A-0D07-44B5-A047-2910AE606C38
p:P478
wds:Q43118400-D29D4A1F-83EF-45DF-8E25-18E33034E7E0
wdt:P433
9
wdt:P478
20
p:P356
wds:Q43118400-CA404732-AE5B-48D0-B5EE-207D33D443AE
wdtn:P356
n11:J.BMCL.2010.03.024
wdt:P356
10.1016/J.BMCL.2010.03.024